Director/PDMR Shareholding

GlaxoSmithKline PLC 03 April 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the directors' interests in the Ordinary Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 31 March 2007, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2007 to 31 March 2007: Non Executive Director Ordinary Shares American Depository Shares (ADSs) Sir Christopher Gent 2,071.33 Dr Stephanie Burns 133.01 Mr Lawrence Culp 498.80 Sir Crispin Davis 1,440.92 Sir Deryck Maughan 498.80 Dr Daniel Podolsky 374.10 Sir Ian Prosser 990.63 Dr Ronaldo Schmitz 576.37 Mr Tom de Swaan 495.32 Sir Robert Wilson 450.29 The Company and the Non-Executive Directors were informed of these allocations on 2 April 2007. This notification relates to transactions notified in accordance with Disclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 3 April 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings